Why a Peninsula cancer fighter soared nearly 40% after record-breaking IPO

As the market fell sharply Thursday, this biotech boomed after raising $324 million in an initial public offering.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.